ANDA 218406, held by Mankind Pharma. Hydrochlorothiazide; Telmisartan.
As of Nov 16, 2026, ANDA 218406 (Telmisartan And Hydrochlorothiazide), held by Mankind Pharma, was first approved by FDA on Mar 3, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 3, 2025 | Original application | Approved | None posted |
| Telmisartan And Hydrochlorothiazide12.5MG;40MG · tablet;oral | Hydrochlorothiazide; Telmisartan | Discontinued |
| Telmisartan And Hydrochlorothiazide12.5MG;80MG · tablet;oral | Hydrochlorothiazide; Telmisartan | Discontinued |
| Telmisartan And Hydrochlorothiazide25MG;80MG · tablet;oral | Hydrochlorothiazide; Telmisartan | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters